Fibrinolysis and diabetic vascular disease: roles of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor

Author： Aso Yoshimasa  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.1, Iss.4, 2006-08, pp. : 429-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombin‐activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 11, 2015-11 ,pp. : 2076-2086

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thrombin activatable fibrinolysis inhibitor (TAFI)—How does thrombin regulate fibrinolysis?

By Bouma Bonno   Mosnier Laurent  

Annals of Medicine, Vol. 38, Iss. 6, 2006-10 ,pp. : 378-388

Informa Healthcare

Access to resources Recommend Favorite

Evolution of Thrombin Formation and Fibrinolysis Markers, Including Thrombin-Activatable Fibrinolysis Inhibitor, during Severe Meningococcemia

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 6, 2006-06 ,pp. : 284-287

Karger

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 257-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 256-257

John Wiley & Sons Inc

Access to resources Recommend Favorite